NDC codes

FDA NDC Directory
Product NDC (as listed)24208-504Labeler and product segments. Claims need a package NDC.
Product NDC at billing width24208-0504Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
24208-504-0124208050401242080504011 BOTTLE in 1 CARTON (24208-504-01) / 2.5 mL in 1 BOTTLEMarketed from Jun 11, 2018 · Sample package
24208-504-0224208050402242080504021 BOTTLE in 1 CARTON (24208-504-02) / 2.5 mL in 1 BOTTLEMarketed from Jun 11, 2018
24208-504-0524208050405242080504051 BOTTLE in 1 CARTON (24208-504-05) / 5 mL in 1 BOTTLEMarketed from Nov 2, 2017
24208-504-0624208050406242080504061 BOTTLE in 1 CARTON (24208-504-06) / 5 mL in 1 BOTTLEMarketed from Nov 2, 2017 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Vyzulta
Generic name (nonproprietary)
latanoprostene bunod
Active ingredients
Latanoprostene bunod — .24 mg/mL
Dosage form
Solution/ drops
Route
Ophthalmic
Labeler
Bausch & Lomb IncorporatedNDC labeler code 24208
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 207795
Marketing start
Listing expires
Identifiers
Product ID 24208-504_12648511-1ae2-aaf8-e063-6394a90a2297SPL ID 12648511-1ae2-aaf8-e063-6394a90a2297SPL set ID 60ce7900-a677-4fc2-88d0-1603baa9dbd4RxCUI 1988394, 1988399UNII I6393O0922

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208050401 followed by a unit qualifier and the quantity

Package 24208-0504-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. VYZULTA is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 24208-504

What is NDC 24208-504?
24208-504 is the product NDC for Vyzulta (latanoprostene bunod), Latanoprostene bunod .24 mg/mL solution/ drops, listed with the FDA by Bausch & Lomb Incorporated. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Vyzulta (Latanoprostene bunod).
What is the active ingredient?
Latanoprostene bunod.
Who is the labeler?
Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vyzulta?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in